Title of article
Inactivation of Myocardin and p16 during Malignant Transformation Contributes to a Differentiation Defect
Author/Authors
Maxim Milyavsky، نويسنده , , Michael and Shats، نويسنده , , Igor and Cholostoy، نويسنده , , Alina and Brosh، نويسنده , , Ran and Buganim، نويسنده , , Yosef and Weisz، نويسنده , , Lilach and Kogan، نويسنده , , Ira S. Cohen، نويسنده , , Merav and Shatz، نويسنده , , Maria and Madar، نويسنده , , Shalom and Kalo، نويسنده , , Eyal and Goldfinger، نويسنده , , Naomi and Yuan، نويسنده , , Jun and Ron، نويسنده , , Shulamit and MacKenzie، نويسنده , , Karen B. Eden، نويسنده , , Amir and Rotter، نويسنده , , Varda، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
14
From page
133
To page
146
Abstract
Summary
din is known as an important transcriptional regulator in smooth and cardiac muscle development. Here we found that myocardin is frequently repressed during human malignant transformation, contributing to a differentiation defect. We demonstrate that myocardin is a transcriptional target of TGFβ required for TGFβ-mediated differentiation of human fibroblasts. Serum deprivation, intact contact inhibition response, and the p16ink4a/Rb pathway contribute to myocardin induction and differentiation. Restoration of myocardin expression in sarcoma cells results in differentiation and inhibition of malignant growth, whereas inactivation of myocardin in normal fibroblasts increases their proliferative potential. Myocardin expression is reduced in multiple types of human tumors. Collectively, our results demonstrate that myocardin is an important suppressive modifier of the malignant transformation process.
Keywords
CELLCYCLE
Journal title
Cancer Cell
Serial Year
2007
Journal title
Cancer Cell
Record number
1336418
Link To Document